4,052 results on '"Hiddemann W"'
Search Results
2. Ethics in Medicine
3. Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment
4. Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL
5. Akute Leukämien
6. Die Lunge bei Systemerkrankungen: Zwischen ganzheitlicher und individualisierter Medizin – eine Herausforderung für die Innere Medizin
7. Generability and quality of leukaemia-derived DC (DCleu) in AML or MDS: conditions and consequences
8. Long-term survival in patients suffering from AML with a complex aberrant karyotype after early allogeneic stem cell transplantation using the FLAMSA-RIC regimen: results from a prospective phase II trial
9. Treatment of Older Patients with Acute Myeloid Leukemia (AML)
10. Randomized Comparison of Sequential High-Dose Cytosine Arabinoside and Idarubicin (S-HAI) with or without Chemo-Modulation by Fludarabine in Refractory and Relapsed Acute Myeloid Leukemia
11. The Impact of Treatment on the Outcome of Cytogenetic Subgroups in Acute Myeloid Leukemia -Results of the German AML Cooperative Group
12. Empirical Antimicrobial Therapy of FUO and Proved Infections in Neutropenic Patients
13. Multivariate Analysis of Prognostic Factors in Patients with Refractory and Relapsed Acute Myeloid Leukemia Undergoing Sequential High-Dose Cytosine Arabinoside and Mitoxantrone (S-HAM) Salvage Therapy: Significance of Cytogenetic Abnormalities
14. Modulation of AraC by Fludarabine: Results of Salvage Therapy by AMLCG
15. RT-PCR in Diagnostics and Monitoring of Acute Myeloid
16. MLL-Duplications are Rare and Associated with Poor Prognosis in Acute Myeloid Leukemia
17. Molecular Characterization of the Translocation (10;11)(p13;q14): MLLandCALMare Fused toAF10in Morphologically Different Subsets of Acute Leukemia
18. Although Patients with AML and Complex Aberrant Karyotype Can be Subdivided Into Different Subtypes by Cytogenetics, Prognosis is Equally Poor
19. Analysis of the Apoptotic Signal Transduction Cascade and New Differentially Expressed Genes in Drug Resistant and Sensitive Hematopoetic Cell Lines
20. Allogeneic transplantation in elderly ppatients with AML and MDS comparing two reduced-intensity regimes [Abstract]
21. AraC Metabolism in Fresh Leukemic Blasts/ Normal Bone Marrow/ Hematopoetic Stem Cells and its Impact on the Lipid Composition of Leukemic Cells (HL60)
22. G-CSF Increases the Number of Trisomy 8 Metaphases in Vitro in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
23. The Prognostic Impact of Trisomy 8 in Acute Myeloid Leukemia: Do Accompanying Aberrations Influence Prognosis?
24. Hematopoietic Growth Factors: Supportive and Priming Effects in AML
25. The Karyotype in MDS — Cytogenetic Profile, Clinical Correlations and Prognostic Implications in 362 Patients with MDS
26. Treatment of Centroblastic-Centrocytic and Centrocytic Lymphomas at Advanced Stages — Results of the German Low-Grade Lymphoma Study Group
27. Failure of Fluconazole Prophylaxis to Reduce Mortality During Treatment for Refractory Acute Myeloid Leukemia: Results of a Phase III Multicenter Study
28. Interventional Antimicrobial Therapy in Febrile Neutropenic Patients (PEG Study II)
29. Detection Limits of Malignant Cells with Leukemia-Associated Phenotype (LAP) in Acute Myeloid Leukemia
30. Clonal Chromosomal Abnormalities in the Stem Cell Compartment of a Patient with Acute Myeloid Leukemia in Hematological Complete Remission
31. Granulocyte Colony-Stimulating Factor Improves the Antileukemic Efficacy of the Sequential High-Dose Cytosine Arabinoside and Mitoxantrone Regimen (S-HAM) in Patients Younger than 60 Years with High-Risk Acute Myeloid Leukemia
32. Superiority of High-Dose over Intermediate-Dose Cytosine Arabinoside (AraC) in the Treatment of Patients with High-Risk Acute Myeloid Leukemia (AML)
33. Treatment of Relapsed and Refractory Acute Myeloid Leukemias — Strategies of the German AML Cooperative Group (AMLCG)
34. All-Trans Retinoic Acid (ATRA) Combined with Double Induction Strategy in Acute Promyelocytic Leukemia (APL). Preliminary Results
35. Biologic Determinants for AML Therapy
36. Involvement of CD34+ Stem Cells in Malignant Transformation in AML and MDS — Genetic Analysis of Sorted Subpopulations by Classical and Molecular Cytogenetics
37. Functional Characterization of Leukemic Stem Cells in Acute Myeloid Leukemia
38. Growth Factors in AML: Updates
39. Fludarabine and Fludarabine, Mitoxantrone, Dexamethasone in the Management of Low-Grade Non-Hodgkin Lymphomas
40. Fludarabine for the Treatment of Advanced Chronic Lymphocytic Leukemia: Results of a Prospective Randomized Comparison with Cyclophosphamide, Doxorubicin and Prednisone
41. Detection of Minimal Residual Disease in Cytogenetically Defined Prognostic Subgroups of AML
42. Correlation of Deoxycytidine Deaminase, Thymidine Kinase and Polymerase Alpha Activity and Deoxycytidine Deaminase Gene Expression In Vivo with Clinical Response to TAD-9+GM-CSF Induction Therapy in Acute Myeloid Leukemia
43. Characterization of Normal and Leukemic Lymphohematopoietic Precursor Cells by Three-Color Flow Cytometry and Detection of Clone-Specific Leukemia-Associated T-Cell Receptor δ Rearrangements
44. IFN-α Is an Inhibitory Cytokine of Leukemic B-Cell Precursors
45. Therapy of Sepsis Syndrome with Human Polyclonal IgM-Enriched Immunoglobulins: Interim Analysis of a Randomized Trial in Neutropenic Cancer Patients
46. Interventional Antimicrobial Strategy in Neutropenic Infections
47. YNK01, an Oral Cytosine Arabinoside Derivative in Acute Myeloid Leukemia and Chronic Myeloid Leukemia
48. Genetic Instability and Evolution of Karyotype in Secondary Acute Myeloid Leukemia
49. Preliminary Results of a Placebo-Controlled, Double-Blind Trial Evaluating Sequential HD-AraC/Mitoxantrone Induction Chemotherapy with or Without Granulocyte-Macrophage Colony-Stimulating Factor in Patients with High-Risk Myelodysplastic Syndromes
50. Intensified Therapy of Acute Myeloid Leukemia: Results of the German AML Cooperative Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.